Mounjaro (tirzepatide) should be discontinued at least one month before you try to become pregnant. It is not approved for use during pregnancy. However, the dramatic weight loss many patients experience on Mounjaro can positively impact fertility by restoring hormonal balance and ovulatory function in those affected by obesity. Working with your provider on timing is critical.

Mounjaro was originally approved for type 2 diabetes, but its weight loss effects have made it one of the most talked-about medications in reproductive health circles. Many patients prescribed Mounjaro are women in their 20s, 30s, and 40s who are actively thinking about family planning.

When to Stop Mounjaro Before Conception

Tirzepatide, the active ingredient in Mounjaro, has a half-life of about five days. After your final injection, it takes roughly four to five weeks for the drug to be effectively eliminated. The prescribing information recommends stopping at least one month before planned pregnancy.

This recommendation is based on animal studies where high doses of tirzepatide caused adverse developmental effects in offspring. Human pregnancy data is not available in sufficient quantity to override this precaution. Planning your washout period in advance with your fertility team ensures a smooth transition from treatment to conception.

How Mounjaro Weight Loss Supports Fertility

Obesity impairs fertility through multiple pathways: excess estrogen from fat tissue, insulin resistance disrupting ovulation, chronic inflammation affecting egg and sperm quality, and higher rates of pregnancy complications. Mounjaro addresses several of these through substantial weight reduction and metabolic improvement.

Patients on Mounjaro in clinical trials lost an average of 15% to 22.5% of their body weight at the highest doses. For someone weighing 250 pounds, that translates to losing 37 to 56 pounds. This magnitude of change can shift a patient from anovulatory to regularly ovulating, from failed IVF cycles to successful ones, and from high-risk pregnancy territory to much safer ground.

Mounjaro and PCOS

Polycystic ovary syndrome is closely linked to insulin resistance and weight. Mounjaro's dual GIP/GLP-1 mechanism addresses both of these factors directly. By improving insulin sensitivity and reducing body weight, Mounjaro may help PCOS patients resume regular ovulatory cycles.

This is a double-edged sword for patients not trying to conceive. If you have PCOS and start ovulating again while on Mounjaro, your risk of unplanned pregnancy increases. Use consistent contraception if pregnancy is not desired. tirzepatide and PCOS

Contraception on Mounjaro

Mounjaro's prescribing information warns that delayed gastric emptying may reduce the effectiveness of oral hormonal contraceptives. The recommendation is to use an additional non-oral backup method for four weeks after starting Mounjaro and for four weeks after each dose increase. IUDs, contraceptive implants, patches, and injectable contraceptives are not affected by gastric motility changes.

Frequently Asked Questions